Purchases and Sales Made in Q4 2023 in Pliant Therapeutics, Inc. (PLRX)
This table provides information about the institutional ownership of Pliant Therapeutics, Inc. (PLRX) during Q4 2023. The information is specifically focused on institutions that hold shares of PLIANT THERAPEUTICS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-21.9K- 21.84% |
$281K - $419K
|
78.3K
$965K
|
|
|
Feb 05, 2024
Q4 2023
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-46.7K- 43.79% |
$601K - $895K
|
60K
$739K
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-66.9K- 46.3% |
$860K - $1.28M
|
77.6K
$956K
|
|
|
Feb 14, 2024
Q4 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-68.8K- 42.63% |
$884K - $1.32M
|
92.6K
$1.14M
|
|
|
Feb 14, 2024
Q4 2023
|
Rock Springs Capital Management LP
Baltimore, MD |
SELL
|
- |
-106K- 21.62% |
$1.36M - $2.03M
|
385K
$4.74M
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-269K- 39.89% |
$3.45M - $5.15M
|
405K
$4.99M
|
|
|
Feb 14, 2024
Q4 2023
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-312K- 71.56% |
$4.01M - $5.98M
|
124K
$1.53M
|